Kaplan Ma

3.5k citations
204 papers · 2.6k · 2 hit papers · h-index 22

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research
    • Occupational and environmental lung diseases
    • Advanced Breast Cancer Therapies
    • Lung Cancer Treatments and Mutations
    • Pleural and Pulmonary Diseases
    • Brain Metastases and Treatment

Papers in

    • Colorectal Cancer Treatments and Studies 12
    • Cancer Treatment and Pharmacology 8
    • HER2/EGFR in Cancer Research 7
    • Occupational and environmental lung diseases 14
    • Lung Cancer Treatments and Mutations 11
    • Brain Metastases and Treatment 7
    • Gastric Cancer Management and Outcomes 7

Kaplan Ma

189 papers receiving 2.6k citations

Kaplan Ma's Hit Papers

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743 2022 · 207 citations
2070+1+3Years since publication100200300400500

Peers

Kaplan Ma
Comparison fields: 5 of 112
  • Oncology 969
  • Pulmonary and Respiratory Medicine 784
  • Cancer Research 255
  • Microbiology 7
  • Hematology 86
Replace Tadashi Mio with:
Tadashi Mio Japan
Faruk Taş Türkiye
Giovanni Rossi Italy
Yener S. Erozan United States
Armin Wiegering Germany
Nobukazu Fujimoto Japan
Danielle Mercatante Carrick United States
Adam Janusz Dziki Poland
Cheng‐Ping Yu Taiwan
Gianluigi Ferretti Italy
Kaplan Ma relative to Tadashi Mio Japan Tadashi Mio's profile →
Citations per field
00.5×2×2.9×
Tadashi Mio · 1×
Citations per year

Countries citing papers authored by Kaplan Ma

Since Specialization
Citations

This map shows the geographic impact of Kaplan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaplan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaplan Ma more than expected).

Fields of papers citing papers by Kaplan Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaplan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaplan Ma. The network helps show where Kaplan Ma may publish in the future.

Co-authors

The 25 scholars most cited alongside Kaplan Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kaplan Ma Line = papers co-authored together Kaplan Ma links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 204 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
Hit paper breakdown →
2021581
2
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743
Hit paper breakdown →
2022207
3 201986
4 200682
5
Amphomycin, a new antibiotic.
195371
6 201062
7 201157
8 201150
9 201241
10 200736
11 201231
12 201331
13 201130
14 202029
15 201328
16 201227
17 201327
18 201326
19 201325
20 201223

About Kaplan Ma

Kaplan Ma is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Otorhinolaryngology and Surgery, having authored 204 papers that have together received 2.6k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (14 papers), Colorectal Cancer Treatments and Studies (12 papers), Lung Cancer Treatments and Mutations (11 papers), Cancer Treatment and Pharmacology (8 papers), HER2/EGFR in Cancer Research (7 papers), Head and Neck Cancer Studies (7 papers), Brain Metastases and Treatment (7 papers) and Gastric Cancer Management and Outcomes (7 papers). The work is most often cited by research in Oncology (969 citations), Pulmonary and Respiratory Medicine (784 citations), Cancer Research (255 citations), Microbiology (7 citations) and Hematology (86 citations). Kaplan Ma has collaborated with scholars based in Türkiye, United States and Brazil. Frequent co-authors include Abdurrahman Işıkdoğan, Zeynep Oruç, Mehmet Küçüköner, Ali̇ İnal, Zuhat Urakçı, Velı Berk, Süleyman Buyukberber, Bernard Heinemann, Mustafa Beneklı and Metin Özkan. Their work appears in journals such as Annals of Oncology, Journal of Chemotherapy, Journal of Cancer Research and Clinical Oncology, Medical Oncology and Photodiagnosis and Photodynamic Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact